LI-COR Biosciences Licenses Prostate-Targeting Molecular Imaging Agent from The Johns Hopkins University

LINCOLN, Neb.--()--LI-COR Biosciences has entered into a licensing agreement with The Johns Hopkins University (Baltimore, MD) for compounds and imaging methods targeting prostate-specific membrane antigen (PSMA) developed in the laboratory of Dr. Martin Pomper. As an enzyme with an extracellular active site, PSMA represents an excellent target for imaging and therapy directed toward solid tumor neovasculature in addition to prostate cancer itself.

LI-COR plans to manufacture a low molecular weight PSMA-based molecular imaging agent, YC-27, labeled with their proprietary infrared dyes as molecular imaging probes for research purposes. The low molecular weight PSMA-based near-infrared imaging agent IRDye 800CW YC-27 was first published by Chen et al. in Biochemical and Biophysical Research Communications in 2009. They concluded that YC-27 was promising for clinical investigation of PSMA-expressing tissue because of its salutary pharmacokinetics in vivo. [Biochem Biophys Res Commun 390: 624 (2009)]

“We are delighted to be able to license Dr. Pomper’s invention from The Johns Hopkins University to provide the research community with a very effective probe for imaging prostate cancer,” says Michael Olive, vice president, Translational Research at LI-COR.

For more information regarding licensing and supply agreements for IRDye 800CW near-infrared fluorescent dye contact Brad Roth Ph.D. at brad.roth@licor.com, 402-467-0778 or visit www.licor.com.

About LI-COR Biosciences:
LI-COR Biosciences is a leading manufacturer of near-infrared imaging platforms, analysis software, and IRDye® infrared dye reagents for quantitative Western blotting, small animal imaging, and DNA fragment analysis.

LI-COR pioneered the development of near-infrared fluorescence detection systems for DNA sequencing, and today provides systems for drug discovery, protein research, small animal imaging, and undergraduate training.

LI-COR instruments for photosynthesis, carbon dioxide analysis and light measurement are recognized worldwide for standard-setting innovation in plant science research and environmental monitoring.

Founded in 1971, the privately held company is based in Lincoln, Nebraska, with subsidiaries in Germany and the United Kingdom. LI-COR systems are used in more than 100 countries and are supported by a global network of distributors.

Contacts

LI-COR Biosciences
Brad Roth Ph.D., 402-467-0778
brad.roth@licor.com
www.licor.com

Release Summary

LI-COR Biosciences has entered into a licensing agreement with The Johns Hopkins University (Baltimore, MD) for compounds and imaging methods targeting prostate-specific membrane antigen (PSMA).

Contacts

LI-COR Biosciences
Brad Roth Ph.D., 402-467-0778
brad.roth@licor.com
www.licor.com